Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences
- First Online:
- Cite this article as:
- Crott, R. & Briggs, A. Eur J Health Econ (2010) 11: 427. doi:10.1007/s10198-010-0233-7
- 546 Views
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized clinical trials or other prospective non-randomized clinical studies, it is rare that preference-based instruments are used that allow the calculation of a utility weight suitable for estimating quality-adjusted life-years gained.
To develop a mapping algorithm to transform the EORTC QLQ-C30 questionnaire responses into EQ-5D derived utilities.
Retrospective data analysis of a multicentre, multicountry prospective clinical trial in breast cancer patients.
Regression analysis of individual pairs of EQ-5D and QLQ-C30 scores.
A model that explained 80% of the variance was developed to estimate EQ-5D Utilities from QLQ-C30 scores at individual level. From this reliable group level means and deviations can be derived.
Mapping from QLQ-C30 scores to EQ-5D-derived utilities when only QLQ-C30 data are available has been shown to be possible with good accuracy. Validation of the proposed algorithm in other external clinical datasets should be encouraged.